Phoenix Molecular Designs Raises $2.7M To Develop PMD-026 for Triple-Negative Breast Cancer (TNBC)

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2MJER9J
via IFTTT